Kidney and heart prevention program after preeclampsia
Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie
University Hospital Schleswig-Holstein · NCT07151339
This program will see if follow-up care plus a biobank can help identify and manage long-term kidney and heart risks for women who had preeclampsia, HELLP, eclampsia, or pregnancy-related kidney disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital Schleswig-Holstein (other) |
| Locations | 1 site (Kiel) |
| Trial ID | NCT07151339 on ClinicalTrials.gov |
What this trial studies
This observational program enrolls adult women diagnosed with preeclampsia, HELLP syndrome, eclampsia, or pregnancy-associated kidney disease and follows them after pregnancy. Participants receive guideline-based clinical follow-up while investigators collect medical data and biological samples to create a biobank. No experimental treatments are provided and care follows national and international recommendations. The collected data and samples will be used to better understand long-term renal and cardiovascular risks and to inform future prevention efforts.
Who should consider this trial
Good fit: Adult women (over 18) with a diagnosis of preeclampsia, HELLP syndrome, eclampsia, or pregnancy-related kidney disease are the intended participants.
Not a fit: Those unable to provide informed consent and people without pregnancy-related hypertensive or kidney conditions are unlikely to receive direct benefit from participation.
Why it matters
Potential benefit: If successful, the program could help identify patients at higher risk of future kidney or heart problems and improve follow-up care and prevention strategies.
How similar studies have performed: Previous cohort and biobank efforts have documented links between preeclampsia and later cardiovascular and renal disease, so this approach builds on existing observational evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * older than 18 yrs * diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy Exclusion Criteria: * unable for informed consent
Where this trial is running
Kiel
- University Hospital Schleswig- Holstein — Kiel, Germany (RECRUITING)
Study contacts
- Study coordinator: Laura K Sievers, MD
- Email: Laura.Rakow@uksh.de
- Phone: +49 431 500 23001
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Preeclampsia, HELLP Syndrome, Eclampsia, Kidney Disease, cardiovascular prevention, preeclampsia, pregnancy